Tag: pharmaceuticals
-
Roche, Biotech to Discover New Antibiotics
A biotechnology company that discovers new drugs through detailed genomic analysis is partnering with drug maker Roche to find new treatments for bacterial infections that resist current antibiotics.
-
Flashback: Drug Pricing Reform Even Big Pharma Might Like
Science & Enterprise is taking a break From 2 to 13 October. Until then, we will re-run some of our recent special reports. Our regular posts will return on 16 October. 2 May 2016. At a press event in Washington, D.C. last week, Representative Lloyd Doggett of Texas, a champion of lower prescription drug prices,…
-
Gas-Jet Printing Process Developed for Medications
A team of material scientists and biomedical engineers designed techniques for producing pharmaceuticals on demand by printing drugs as thin films.
-
Biotech Licenses Gene Editing for Autoimmune Disorders
A company developing therapies with gene editing technologies is acquiring a new form of gene editing on T-cells in the immune system to treat autoimmune diseases.
-
Gene Therapy Shown to Prevent, Reverse Multiple Sclerosis
Medical researchers show that transferring healthy genes can protect nerve cells in lab mice against damage from multiple sclerosis, and help reverse effects of the disease.
-
Patent Awarded for Live Bacterial Acne Treatment
A company developing treatments for disease by restoring the natural balance of bacteria on the skin received a patent for its acne therapy using spray-on live bacteria.
-
Guidelines Designed for CAR T-Cell Cancer Therapies
Cancer specialists and scientists at several cancer care centers propose safety guidelines for patients receiving engineered immune cell treatments that often have severe adverse effects.
-
Neuro Disease Start-Up Gains $30M in Early Funds
A start-up enterprise developing treatments for several neurological diseases that the company says are triggered by a common destructive protein, is raising $30 million its first venture financing round.
-
Avian Flu Vaccine with Longer Protection in Development
A biotechnology company is designing a vaccine to protect against the newly emergent avian flu to provide more sustained protection like seasonal flu vaccines.
-
Drug Delivery Technology Licensed in $2B Deals
The biotechnology company Halozyme Therapeutics Inc. is licensing its technology for making infusion drugs deliverable with injections to two more drug makers.